National Graphite Corp. (NGRC) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for National Graphite Corp. (NGRC).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.0432

Daily Change: $0.00 / 0.00%

Daily Range: $0.0432 - $0.0488

Market Cap: $6,635,244

Daily Volume: 4,400

Performance Metrics

1 Week: -9.12%

1 Month: 7.90%

3 Months: -0.78%

6 Months: 34.45%

1 Year: -19.33%

YTD: 25.74%

Details

National Graphite Corp., through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company. The company collaborates with clinical stage companies that develop new biological entities or new therapeutically platforms for the treatment of various diseases, rare diseases, and diseases with unmet needs. It is developing a drug candidate called ELAFIN, which is a human identic protein for the treatment of postoperative inflammatory complications. National Graphite Corp. has a collaboration agreement with Proteo Inc. for developing ELAFIN. The company was formerly known as Lucky Boy Silver Corporation and changed its name to National Graphite Corp. in May 2012. National Graphite Corp. was founded in 2006 and is based in Duesseldorf, Germany.

Selected stocks

Neometals Ltd. (NMTAF)

Toro Energy Ltd. (TOEYF)

Metro Mining Ltd. (MMILF)